TOVX
Theriva Biologics Inc.
NYSE MKT: TOVX · HEALTHCARE · BIOTECHNOLOGY
$0.36
+8.67% today
Updated 2026-04-30
Market cap
$16.23M
P/E ratio
—
P/S ratio
22.32x
EPS (TTM)
$-2.08
Dividend yield
—
52W range
$0 – $1
Volume
31.8M
Theriva Biologics Inc. (TOVX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-137.80%
ROA
-25.50%
Debt/equity
0.41x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | — | $-4.10M | — | — | — |
| 2007 | — | $-9.89M | — | — | — |
| 2008 | — | $-7.21M | — | — | — |
| 2009 | $103089.00 | $-3.73M | 100.00% | -3,571.17% | -3,619.60% |
| 2010 | $3.16M | $-1.71M | 85.22% | -50.05% | -54.07% |
| 2011 | — | $-8.15M | — | — | — |
| 2012 | — | $-17.07M | — | — | — |
| 2013 | — | $-12.32M | — | — | — |
| 2014 | — | $-19.78M | — | — | — |
| 2015 | — | $-43.74M | — | — | — |
| 2016 | — | $-27.25M | — | — | — |
| 2017 | — | $-15.17M | — | — | — |
| 2018 | $0.00 | $-13.37M | — | — | — |
| 2019 | $0.00 | $-15.30M | — | — | — |
| 2020 | $0.00 | $-10.04M | — | — | — |
| 2021 | $0.00 | $-14.17M | — | — | — |
| 2022 | $0.00 | $-19.68M | — | — | — |
| 2023 | $0.00 | $-18.35M | — | — | — |
| 2024 | $0.00 | $-25.65M | — | — | — |
| 2025 | $0.00 | $-25.25M | — | — | — |